Gangamai Diagnostic Center Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 30-06-2024
- Paid Up Capital ₹ 4.00 M
as on 30-06-2024
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.32 Cr
as on 30-06-2024
- Revenue 50.58%
(FY 2022)
- Profit 128.41%
(FY 2022)
- Ebitda -12.77%
(FY 2022)
- Net Worth 24.74%
(FY 2022)
- Total Assets 26.14%
(FY 2022)
About Gangamai Diagnostic Center
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹1.32 Cr.
Prabhakar Shankaran and Malathi Sitaraman serve as directors at the Company.
- CIN/LLPIN
U85100PN2012PTC143871
- Company No.
143871
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Solapur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gangamai Diagnostic Center?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabhakar Shankaran  | Director | 29-Jun-2012 | Current |
| Malathi Sitaraman | Director | 26-Sep-2018 | Current |
Financial Performance of Gangamai Diagnostic Center.
Gangamai Diagnostic Center Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 50.58% increase. The company also saw a substantial improvement in profitability, with a 128.41% increase in profit. The company's net worth Soared by an impressive increase of 24.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gangamai Diagnostic Center?
In 2019, Gangamai Diagnostic Center had a promoter holding of 96.50% and a public holding of 3.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Neomaxx Pharmaceuticals Private LimitedActive 5 years 3 monthsPrabhakar Shankaran is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Mahesh Urban Co - Operative Bank Limited Creation Date: 20 Mar 2013 | ₹3.20 M | Open |
Vikas Sahakari Bank Limited Creation Date: 12 Nov 2012 | ₹1.00 Cr | Open |
How Many Employees Work at Gangamai Diagnostic Center?
Gangamai Diagnostic Center has a workforce of 4 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gangamai Diagnostic Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gangamai Diagnostic Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
